Old Web
English
Sign In
Acemap
>
authorDetail
>
Maria Celeridad
Maria Celeridad
Discovery Institute
Cancer research
Chemistry
Drug discovery
Kinase
In vitro
5
Papers
23
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Inhibitors of the Hippo Pathway Kinases STK3/MST2 and STK4/MST1 Have Utility for the Treatment of Acute Myeloid Leukemia.
2021
Journal of Medicinal Chemistry
Nicole Bata
Apirat Chaikuad
Nicole A. Bakas
Allison S. Limpert
Lester J. Lambert
Douglas J. Sheffler
Lena M. Berger
Guoxiong Liu
Cunxiang Yuan
Li Wang
Yi Peng
Jing Dong
Maria Celeridad
Fabiana I. A. L. Layng
Stefan Knapp
Nicholas D.P. Cosford
Show All
Source
Cite
Save
Citations (0)
Development of a Robust High-Throughput Screening Platform for Inhibitors of the Striatal-Enriched Tyrosine Phosphatase (STEP).
2021
International Journal of Molecular Sciences
Lester J. Lambert
Stefan Grotegut
Maria Celeridad
Palak Gosalia
Laurent Js De Backer
Andrey A. Bobkov
Sumeet Salaniwal
Thomas D.Y. Chung
Fu-Yue Zeng
Ian Pass
Paul J. Lombroso
Nicholas D.P. Cosford
Lutz Tautz
Show All
Source
Cite
Save
Citations (2)
A cellular target engagement assay for the characterization of SHP2 (PTPN11) phosphatase inhibitors
2020
Journal of Biological Chemistry
Celeste Romero
Lester J. Lambert
Douglas J. Sheffler
Laurent Jean Stephane De Backer
Dhanya Raveendra-Panickar
Maria Celeridad
Stefan Grotegut
Socorro Rodiles
John Holleran
Eduard Sergienko
Elena B. Pasquale
Nicholas D.P. Cosford
Lutz Tautz
Show All
Source
Cite
Save
Citations (6)
Pharmacological Activation of Non-canonical NF-κB Signaling Activates Latent HIV-1 Reservoirs In Vivo
2020
Lars Pache
Matthew D. Marsden
Peter Teriete
Alex J. Portillo
Dominik Heimann
Jocelyn T. Kim
Mohamed S. A. Soliman
Melanie Dimapasoc
Camille Carmona
Maria Celeridad
Adam M. Spivak
Vicente Planelles
Nicholas D.P. Cosford
Jerome A. Zack
Sumit K. Chanda
Show All
Source
Cite
Save
Citations (11)
Design, Synthesis, and Characterization of an Orally Active Dual-Specific ULK1/2 Autophagy Inhibitor that Synergizes with the PARP Inhibitor Olaparib for the Treatment of Triple-Negative Breast Cancer.
2020
Journal of Medicinal Chemistry
Huiyu Ren
Nicole A. Bakas
Mitchell Vamos
Apirat Chaikuad
Allison S. Limpert
Carina Wimer
Sonja N. Brun
Lester J. Lambert
Lutz Tautz
Maria Celeridad
Douglas J. Sheffler
Stefan Knapp
Reuben J. Shaw
Nicholas D.P. Cosford
Show All
Source
Cite
Save
Citations (4)
1